Latest news
Loading news…
Zyngenia
ClosedOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 LowHeat score — how much recent activity & attention the company has (web traffic, news, hiring). Gaithersburg, Maryland, United States Founded 2008 11-50 employees For Profit
Zyngenia is a biotherapeutics company focused on the development of the next-generation of antibody-derived drugs.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Monthly Visits
Available in Pro Contacts
3
Patents
9
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Private
- Valuation range
- $100M to $500M
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 3
- Active products
- 5
- Patents granted
- 9
- Trademarks
- 0
- Top patent class
- Organic Chemistry
- IT spend
- $484K
Company Info
- Founded
- 2008
- Employees
- 11-50
- Operating status
- Closed
- Company type
- For Profit
- Org types
- company
- Founders
- 2
- News articles
- 3
- HQ
- Gaithersburg, Maryland, United States
- Region
- Washington DC Metro Area, East Coast, Southern US
Signals & Scores
- Heat score
- Low
- Trend (7d)
- -0.9
- Trend (30d)
- -2
- Trend (90d)
- 6.3
3
professional contacts at Zyngenia
Contact execs at Zyngenia →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Zyngenia
Loading news…
FAQs about Zyngenia
People who checked this page also checked these
Browse the full Acquirezy directory.